Genmab A/S (GMAB)
26.87
-0.18
(-0.67%)
USD |
NASDAQ |
May 22, 16:00
26.78
-0.09
(-0.33%)
Pre-Market: 09:24
Genmab Market Cap : 16.55B for May 22, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Ascendis Pharma A/S | 15.26B |
| Zealand Pharma A/S | 3.541B |
| Bavarian Nordic A/S | 2.365B |
| Bioporto A/S | 50.17M |
| Evaxion AS | 34.03M |
Market Cap Related Metrics
| PE Ratio | 20.26 |
| PS Ratio | 4.374 |
| Price to Book Value | 2.913 |
| Price to Free Cash Flow | 19.55 |
| Price | 26.87 |
| Earnings Yield | 4.94% |
| Operating PE Ratio | 13.26 |
| Normalized PE Ratio | 17.14 |